0000899243-22-032265.txt : 20220929
0000899243-22-032265.hdr.sgml : 20220929
20220929204826
ACCESSION NUMBER: 0000899243-22-032265
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220927
FILED AS OF DATE: 20220929
DATE AS OF CHANGE: 20220929
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farrow Jeffrey S
CENTRAL INDEX KEY: 0001405253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37539
FILM NUMBER: 221281925
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc.
CENTRAL INDEX KEY: 0001629137
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274825712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650741-7700
MAIL ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-27
0
0001629137
Global Blood Therapeutics, Inc.
GBT
0001405253
Farrow Jeffrey S
C/O GLOBAL BLOOD THERAPEUTICS, INC.
181 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
Common Stock
2022-09-27
4
M
0
23653
16.40
A
26739
D
Stock Option (Right to Buy)
16.40
2022-09-27
4
M
0
23653
0.00
D
2027-01-16
Common Stock
23653
10299
D
The shares of Common Stock underlying the option vested in equal quarterly installments over 16 quarters from January 17, 2017 through January 17, 2021.
/s/ Miguel Carrillo, Attorney-in-Fact
2022-09-29